Pages that link to "Q68194781"

The following pages link to Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age (Q68194781):

Displaying 19 items.

• Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? (Q34706329) (← links)
• Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine (Q35792937) (← links)
• Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines (Q38184785) (← links)
• Vaccination of adults against travel-related infectious diseases, and new developments in vaccines (Q38981194) (← links)
• Evolving concepts in pediatric bacterial meningitis--Part I: Pathophysiology and diagnosis (Q40768753) (← links)
• Evolving concepts in pediatric bacterial meningitis--Part II: Current management and therapeutic research (Q40768757) (← links)
• Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection (Q43886218) (← links)
• Impact of vaccination against Haemophilus influenzae on the incidence of invasive infections from Haemophilus influenzae type B in the Nord-Pas-de-Calais region (Q44140589) (← links)
• Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens (Q48029836) (← links)
• Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. (Q64990656) (← links)
• Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants (Q68226933) (← links)
• Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children (Q70607995) (← links)
• Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy (Q71877634) (← links)
• Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections (Q72344517) (← links)
• Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age (Q73315972) (← links)
• Immunogenicity and safety of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP‐T) presented in a dual‐chamber syringe with DTP (Q74110022) (← links)
• Antibody response to Haemophilus influenzae type b tetanus conjugate vaccine with two doses given at 3 and 5 months of age (Q74471662) (← links)
• Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T) (Q74503632) (← links)
• Methodologic reporting requirements for clinical trials: advancing the science today and tomorrow (Q84565651) (← links)